Polyp Guideline: Diagnosis, Treatment, and Surveillance for Patients with Nonfamilial Colorectal Polyps*

  1. John H. Bond, MD
  1. For the Practice Parameters Committee of the American College of Gastroenterology. Requests for Reprints: American College of Gastroenterology, 4900 B South 31st Street, Arlington, VA 22206-1656.

    Abstract

    Objective: To outline the preferable approach to the management of patients with nonfamilial colorectal polyps.

    Data Sources: The human subject English language literature for the past 15 years, searched using MEDLINE and the terms polyp-, adenoma-, and polypectomy-colorectal.

    Study Selection: The titles and abstracts of all pertinent articles were reviewed. All randomized, controlled trials and large casecontrol and cohort studies related to colorectal polyps were reviewed in depth.

    Data Synthesis: Evidence was evaluated along a hierarchy with randomized, controlled trials receiving the greatest weight. Conclusions and recommendations were reviewed by a large group of experts in gastroenterology, radiology, and pathology and were circulated for comment to primary care medical societies.

    Conclusions: Most patients with polyps should undergo colonoscopy to excise the polyp and search for synchronous neoplasms. Small polyps (<0.5 cm) require individualization. A hyperplastic polyp found during proctosigmoidoscopy is not an indication for colonoscopy. Large sessile polyps require careful follow-up to ensure complete resection. The need for further treatment of a resected polyp with invasive carcinoma depends on several well-defined clinical and pathologic criteria. Follow-up surveillance after polypectomy should be tailored to the individual risk assessment for each patient. Initial follow-up should be performed at 3 years for most postpolypectomy patients. After one negative result of a 3-year examination, the interval can be increased to 5 years. Patients with one small tubular adenoma do not have an increased risk for cancer, and therefore follow-up surveillance may not be indicated. Adoption of these recommendations should substantially reduce the cost of postpolypectomy surveillance and of screening for colorectal cancer.

    * This guideline has been officially endorsed by the American Society for Gastrointestinal Endoscopy and the American Gastroenterological Association. It is an official statement of the American College of Gastroenterology. For a list of the members of the Practice Parameters Committee of the American College of Gastroenterology, see end of text.

    « Previous | Next Article »Table of Contents